Description
Regular Meeting
The Cambridge Biosafety Committee meeting meets on a monthly basis so that members may conduct its oversight activities as granted under the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Biosafety Regulation of 2009.
AGENDA (Link to PDF)
Cambridge Biosafety Committee
Thursday, Dec 19, 2019, 3:00 pm
119 Windsor Street
Introductions
Presentations
Triplet Therapeutics (Eva Asp) will present a request for a new BSL-1/BSL-2 permit for their facility at 215 First Street, 4th Floor
Glympse Bio (Wendy Winckler) will present a request for a new BSL-1/BSL-2 permit for their facility at 35 CambridgePark Drive, Suite 100.
Elicio Therapeutics (Ana Castano) will present a request for a new BSL-1/BSL-2permit for their facility at One Kendall Square, Bldg 1400W, 3rd Floor.
Old Business/Site visits
Oct 18 – CRISPR Therapeutics (200 Sidney Street, 3rd Fl) BSL-2 ONLY amendment walkthrough
Oct 22 – Sai Life Sciences (400 Technology Square, 2nd Fl) BSL-1/BSL-2 new permit walkthrough
Nov 4 – Directed Genomics (99A Erie Street) BSL-2 ONLY new permit walkthrough
Dec 17 – Alnylam Pharmaceuticals (675 West Kendall Street) BSL-1/BSL-2 amendment walkthrough
New Business
Adjourn